This study investigates an investigational treatment for individuals with moderate to severe acne vulgaris. Acne vulgaris is a common skin condition characterized by pimples, blackheads, and cysts that can occur on the face and other parts of the body. The purpose of this study is to evaluate the effectiveness of the investigational product in reducing the number of acne lesions.

Participants in this study will be asked to apply the investigational product to their face as directed. The study will assess the number of inflammatory and non-inflammatory lesions on the face before and after treatment. Participants will need to follow specific guidelines to ensure the accuracy of the study results.

• Who can participate: Participants must be male or non-pregnant female at least 9 years old with a clinical diagnosis of moderate to severe acne vulgaris. They should have at least 20 inflammatory and 20 non-inflammatory lesions on the face. Participants must be willing to apply the investigational product and comply with the study protocol.
• Study details: Participants will apply the investigational product as directed. They must not be using any other topical therapies on the face that could affect acne. The study involves following specific guidelines to ensure accurate results.